Generic Combination Products May Be Permitted Delivery Device Variations
Executive Summary
But US FDA officials say brand vs. generic product differences won't be appropriate in all cases and patient misuse remains a concern.
You may also be interested in...
US FDA Investigating Auto-Injector Problems With Copaxone Generics
Reports of bent needles and injector failures also raise questions about the FDA’s complex product approval process.
US FDA Investigating Auto-Injector Problems With Copaxone Generics
Reports of bent needles and injector failures also raise questions about the FDA’s complex product approval process.
FDA Eyes Adverse Events For Mylan's Wixela Inhub
As patients log device complaints for Mylan’s Advair Diskus generic Wixela Inhub, the agency is assessing whether additional reminders about the products’ differences are needed.